Furthermore, Western blot analysis revealed that compared to shLuc control, both Klk8 shRNAs significantly enriched the tumor lysates for uncleaved A110 relative to A30 at least by the time the tumors reached the endpoint (Fig. 5F, G). The gene discussed is KLK8; the disease is neoplasm.